Luka Lezaic
Overview
Explore the profile of Luka Lezaic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
37
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rep S, Sirca K, Lezaic E, Zaletel K, Hocevar M, Lezaic L
Radiol Oncol
. 2024 Nov;
58(4):486-493.
PMID: 39608010
Background: Minimally invasive parathyroidectomy is the treatment of choice in patients with primary hyperparathyroidism (PHP), but it needs a reliable preoperative localization method to detect hyperfunctioning parathyroid tissue. Higher sensitivity...
2.
Strojan P, Plavc G, Kokalj M, Mitrovic G, Blatnik O, Lezaic L, et al.
Radiol Oncol
. 2023 Dec;
57(4):538-549.
PMID: 38038413
Background: Xerostomia is a common side effect of radiotherapy in patients with head and neck tumors that negatively affects quality of life. There is no known effective standard treatment for...
3.
Opalinska M, Lezaic L, Decristoforo C, Kolenc P, Mikolajczak R, Studen A, et al.
Eur J Nucl Med Mol Imaging
. 2023 Jul;
50(13):4110-4111.
PMID: 37452871
No abstract available.
4.
Mrak M, Pavsic N, Zizek D, Lezaic L, Bunc M
J Cardiovasc Dev Dis
. 2023 Jun;
10(6).
PMID: 37367400
Coronary sinus reducer (CSR) implantation is a new treatment option for patients with refractory angina pectoris. However, there is no evidence from a randomized trial that would show an improvement...
5.
Hropot T, Herman R, Janez A, Lezaic L, Jensterle M
Int J Mol Sci
. 2023 May;
24(10).
PMID: 37239935
Adipose tissue can be divided into white adipose tissue (WAT), brown adipose tissue (BAT), and beige adipose tissue, according to the differences in morphology. WAT acts as a buffer for...
6.
Rus T, Mlakar J, Lezaic L, Vo A, Nguyen N, Tang C, et al.
Eur J Neurol
. 2022 Dec;
30(4):1035-1047.
PMID: 36583625
Background And Purpose: Although sporadic Creutzfeldt-Jakob disease (sCJD) is a rare cause of dementia, it is critical to understand its functional networks as the prion protein spread throughout the brain...
7.
Jensterle M, Ferjan S, Lezaic L, Socan A, Goricar K, Zaletel K, et al.
Diabetes Obes Metab
. 2022 Dec;
25(4):975-984.
PMID: 36511825
Aim: To evaluate the effect of once-weekly subcutaneous semaglutide 1.0 mg on the late digestive period of gastric emptying (GE) after ingestion of a standardized solid test meal by using...
8.
Jarabek L, Jamsek J, Cuderman A, Rep S, Hocevar M, Kocjan T, et al.
Radiol Oncol
. 2022 Dec;
56(4):440-452.
PMID: 36503715
Background: In the setting of primary hyperparathyroidism (PHPT), [F]fluorocholine PET/CT (FCH-PET) has excellent diagnostic performance, with experienced practitioners achieving 97.7% accuracy in localising hyperfunctioning parathyroid tissue (HPTT). Due to the...
9.
Lezaic L, Erba P, Decristoforo C, Zaletel K, Mikolajczak R, Maecke H, et al.
Eur J Nucl Med Mol Imaging
. 2022 Nov;
50(3):892-907.
PMID: 36334104
Introduction: Medullary thyroid cancer (MTC) is a rare malignant tumour of the parafollicular C-cells with an unpredictable clinical course and currently suboptimal diagnostic and therapeutic options, in particular in advanced...
10.
Tomse P, Rebec E, Studen A, Perovnik M, Rus T, Lezaic L, et al.
Phys Med
. 2022 May;
98:131-138.
PMID: 35537328
Purpose: Differentiation between neurodegenerative parkinsonisms, whose early clinical presentation is similar, may be improved with metabolic brain imaging. In this study we applied a specific network analysis to 2-[F]FDG PET...